{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:53:52Z","timestamp":1790916832191,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":209,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101346","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:01:56Z","timestamp":1785898916000},"page":"101346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["CD103+ tissue-resident T-cells in head and neck squamous cell carcinomas of patients treated anti-PD-1 therapy"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5886-1059","authenticated-orcid":false,"given":"Christine","family":"Sanders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahlia","family":"Kittel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5298-9880","authenticated-orcid":false,"given":"Annkristin","family":"Heine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Strieth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Hattenhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6891-8705","authenticated-orcid":false,"given":"Rebekka","family":"Mispelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimo","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4149-5487","authenticated-orcid":false,"given":"Glen","family":"Kristiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Brossart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4803-3712","authenticated-orcid":false,"given":"Marieta Ioana","family":"Toma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ctarc.2026.101346_bib0001","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41419-019-1769-9","article-title":"Clinical update on head and neck cancer: molecular biology and ongoing challenges","volume":"10","author":"Alsahafi","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ctarc.2026.101346_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.705096","article-title":"Anti\u2013PD-1 and anti\u2013PD-L1 in head and neck cancer: a network meta-analysis","volume":"12","author":"Botticelli","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101346_bib0003","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.oraloncology.2018.04.008","article-title":"Nivolumab vs investigator\u2019s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression","volume":"81","author":"Ferris","year":"2018","journal-title":"Oral Oncol."},{"issue":"6382","key":"10.1016\/j.ctarc.2026.101346_bib0004","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ctarc.2026.101346_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00672","article-title":"Resistance mechanisms of anti-PD1\/PDL1 therapy in solid tumors","volume":"8","author":"Lei","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"32","key":"10.1016\/j.ctarc.2026.101346_bib0006","doi-asserted-by":"crossref","first-page":"52889","DOI":"10.18632\/oncotarget.17547","article-title":"PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma","volume":"8","author":"M\u00fcller","year":"2017","journal-title":"Oncotarget"},{"issue":"26","key":"10.1016\/j.ctarc.2026.101346_bib0007","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti\u2013PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101346_bib0008","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101346_bib0009","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41591-018-0045-3","article-title":"Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing","volume":"24","author":"Guo","year":"2018","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101346_bib0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nri2251","article-title":"Shaping and reshaping CD8+ T-cell memory","volume":"8","author":"Harty","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"7706","key":"10.1016\/j.ctarc.2026.101346_bib0011","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-018-0130-2","article-title":"Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates","volume":"557","author":"Simoni","year":"2018","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101346_bib0012","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1158\/2326-6066.CIR-15-0097","article-title":"Progression of lung cancer is associated with increased dysfunction of T cells defined by coexpression of multiple inhibitory receptors","volume":"3","author":"Thommen","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"24","key":"10.1016\/j.ctarc.2026.101346_bib0013","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.3390\/cancers13246211","article-title":"Integrin \u03b1E(CD103)\u03b27 in epithelial cancer","volume":"13","author":"Hoffmann","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101346_bib0014","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.juro.2015.02.2941","article-title":"CD103 + tumor infiltrating lymphocytes predict a favorable prognosis in urothelial cell carcinoma of the bladder","volume":"194","author":"Wang","year":"2015","journal-title":"J. Urol."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101346_bib0015","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.4049\/jimmunol.1402711","article-title":"CD8+CD103+ tumor\u2013infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients","volume":"194","author":"Djenidi","year":"2015","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101346_bib0016","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1038\/s41467-018-05072-0","article-title":"Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors","volume":"9","author":"Duhen","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101346_bib0017","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1158\/1078-0432.CCR-23-0445","article-title":"Tumor-infiltrating CD103+ tissue-resident memory T cells and CD103\u2212CD8+ T cells in HNSCC are linked to outcome in primary but not metastatic disease","volume":"30","author":"von Witzleben","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101346_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002231","article-title":"Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade","volume":"9","author":"Banchereau","year":"2021","journal-title":"J. ImmunOther Cancer"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101346_bib0019","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/s41416-022-01725-6","article-title":"CD103+CD8+ tissue-resident memory T cell infiltration predicts clinical outcome and adjuvant therapeutic benefit in muscle-invasive bladder cancer","volume":"126","author":"Jin","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"16","key":"10.1016\/j.ctarc.2026.101346_bib0020","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1016\/j.cell.2022.06.018","article-title":"Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy","volume":"185","author":"Luoma","year":"2022","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.ctarc.2026.101346_bib0021","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.1158\/0008-5472.CAN-08-3571","article-title":"Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention","volume":"69","author":"Franciszkiewicz","year":"2009","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101346_bib0022","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/cac2.12480","article-title":"Intratumoral CD103+ CD8+ T cells cells predict response to neoadjuvant chemoimmunotherapy in advanced head and neck squamous cell carcinoma","volume":"43","author":"Ren","year":"2023","journal-title":"Cancer Commun."},{"issue":"87","key":"10.1016\/j.ctarc.2026.101346_bib0023","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adf4968","article-title":"Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti\u2013PD-1 in head and neck cancer","volume":"8","author":"Oliveira","year":"2023","journal-title":"Sci. Immunol."},{"issue":"13","key":"10.1016\/j.ctarc.2026.101346_bib0024","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1158\/1078-0432.CCR-17-2257","article-title":"CD103+ tumor-resident CD8+ T cells are associated with improved survival in immunotherapy-na\u00efve melanoma patients and expand significantly during anti\u2013PD-1 treatment","volume":"24","author":"Edwards","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101346_bib0025","article-title":"CD103+CD8+ TRM cells accumulate in tumors of anti-PD-1-responder lung cancer patients and are tumor-reactive lymphocytes enriched with Tc17","volume":"1","author":"Corgnac","year":"2020","journal-title":"Cell Rep. Med."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101346_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005248","article-title":"Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination","volume":"10","author":"van der Woude","year":"2022","journal-title":"J. ImmunOther Cancer"},{"key":"10.1016\/j.ctarc.2026.101346_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.106226","article-title":"Prognostic value of CD103+ tumor-infiltrating lymphocytes and programmed death ligand-1 (PD-L1) combined positive score in recurrent laryngeal squamous cell carcinoma","volume":"135","author":"Smith","year":"2022","journal-title":"Oral Oncol."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101346_bib0028","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009550","article-title":"Immune cell topography of head and neck cancer","volume":"12","author":"Muijlwijk","year":"2024","journal-title":"J. ImmunOther Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101346_bib0029","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000452","article-title":"CD103+ tumor-resident CD8+ T cell numbers underlie improved patient survival in oropharyngeal squamous cell carcinoma","volume":"8","author":"Hewavisenti","year":"2020","journal-title":"J. ImmunOther Cancer"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101346_bib0030","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.annonc.2022.04.074","article-title":"Prognostic stratification of HPV-associated oropharyngeal cancer based on CD103+ immune cell abundance in patients treated on TROG 12.01 and De-ESCALaTE randomized trials","volume":"33","author":"Rischin","year":"2022","journal-title":"Ann. Oncol."},{"issue":"13","key":"10.1016\/j.ctarc.2026.101346_bib0031","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1177\/0022034519882618","article-title":"CD103+ T and dendritic cells indicate a favorable prognosis in oral cancer","volume":"98","author":"Xiao","year":"2019","journal-title":"J. Dent. Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101346_bib0032","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001807","article-title":"CD8+CD103+ tissue-resident memory T cells convey reduced protective immunity in cutaneous squamous cell carcinoma","volume":"9","author":"Lai","year":"2021","journal-title":"J. ImmunOther Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101346_bib0033","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.imbio.2012.04.012","article-title":"Increased intraepithelial (CD103+) CD8+ T cells in the airways of smokers with and without chronic obstructive pulmonary disease","volume":"218","author":"Mikko","year":"2013","journal-title":"Immunobiology"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101346_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051862","article-title":"Cutoff finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization","volume":"7","author":"Budczies","year":"2012","journal-title":"PLoS One"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:57:38Z","timestamp":1790913458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226002571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":34,"alternative-id":["S2468294226002571"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101346","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD103+ tissue-resident T-cells in head and neck squamous cell carcinomas of patients treated anti-PD-1 therapy","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101346","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101346"}}